Navigation Links
Multidisciplinary meeting on urological cancers aims to benefit cancer patients
Date:11/19/2009

Arnhem, November 2009 -- Experts agree that the urological cancer patient will benefit greatly if the delivered treatment is the result of a combined effort. Collaboration of experts from various fields is, therefore, necessary to take cancer-related research and medical practice to the next level. The 2nd European Multidisciplinary Meeting on Urological Cancers (EMUC) Embracing Excellence in Prostate, Bladder and Kidney Cancer - which is to take place on 27-29 November 2009 in Barcelona (ES), brings together urologists, radiologists and medical oncologists by enabling them to share their knowledge and experience. The meeting is organised by the European Association of Urology (EAU), the European Society for Medical Oncology (ESMO) and the European Society for Therapeutic Radiology and Oncology (ESTRO) and was first held two years ago.

With the objective to facilitate multidisciplinary approaches that aim to optimise diagnostic, therapeutic and preventional interventions directed towards malignant disorders in the urogenital tract, the 2nd EMUC Meeting will feature presentations on the latest research from selected, translational and clinical abstracts, as well as related scientific and educational sessions.

"Meetings such as these are of great significance in promoting further scientific collaboration, not just on an international level, but even more so between the various experts working in the challenging and fast evolving fields of prostate, bladder and renal cell cancer", says Prof. Per-Anders Abrahamsson from Malm (SE), member of the EMUC Organising Steering Committee on behalf of the EAU.

Screening for prostate cancer, a much debated subject with far-reaching consequences, is one of the interesting issues on the meeting's agenda. According to Prof. Jos Baselga, Barcelona (ES), member of the EMUC Organising Steering Committee on behalf of the ESMO: "New compounds for the treatments of castrate-resistant prostate cancer and advanced renal cell carcinoma will be discussed. Furthermore, subjects such as urine markers in the screening of bladder cancer and new systemic treatment modalities in advanced bladder cancer are highlighted in State-of-the-art lectures and debates during the meeting".

The meeting enables experts to present the most recent advances in prostate, bladder and renal cell cancer and spans the entire field; from bench research to clinical applications which should be of interest to both clinicians and basic scientists. The future of European (and worldwide) urological cancer research will largely depend on advances in these fields.

"The involvement of world experts in their fields, the broad spectrum of topics discussed including biology, prevention, diagnosis, therapy and quality of life issues should guarantee comprehensive coverage", says Prof. Michael Baumann, Dresden (DE), member of the EMUC Organising Steering Committee on behalf of the ESTRO.

A multidisciplinary approach in urooncological patient care will eventually become an essential part of routine health care. For that reason, collaboration between academia, health care providers in general, but especially among urologists, radiation oncologists and medical oncologists will be the future.

Barcelona with its many cultural and culinary wonders will be an entertaining and interesting backdrop for this meeting.


'/>"/>

Contact: Lindy Brouwer
l.brouwer@uroweb.org
European Association of Urology
Source:Eurekalert

Related medicine news :

1. Mayo Clinic Multidisciplinary Simulation Center Receives Distinction as an ACS-Accredited Education Institute
2. SAGE launching new sports medicine journal in 2009: Sports Health: A Multidisciplinary Approach
3. APTAs Multidisciplinary Summit Establishes Opportunities for Physical Therapists to Drive Health Care Change
4. Elsevier Launches SciVal Spotlight: New Tool Provides Multidisciplinary View of Research Performance
5. ECCO 15 -- ESMO 34 multidisciplinary cancer congress
6. Media registration for ECCO 15 -- ESMO 34 multidisciplinary cancer congress
7. Bayer and Onyx Announce Nexavar Data Presentations at the Joint 15th European CanCer Organisation (ECCO) and 34th European Society for Medical Oncology (ESMO) Multidisciplinary Congress
8. Mastery of Myeloma Continuing Education Training Program for the Multidisciplinary Care Team Set for Western Region
9. Manor Care, Inc. Announces Record Date for Special Stockholder Meeting
10. Par Pharmaceutical Files Form 10-K for 2006 -- Company to Hold First Analysts Meeting September 28, 2007
11. Kyphon Announces Special Meeting Date to Vote on Proposed Medtronic Merger
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... (PRWEB) , ... December 02, 2016 , ... For over twenty-four years, Doctors on ... to help personal injury victims find high quality medical care. When the company started ... area. Fast forward to present day and the now ten-page directory features a vast ...
(Date:12/2/2016)... ... December 02, 2016 , ... Center for Autism and Related Disorders (CARD) Portland ... autism spectrum disorder (ASD) and other developmental disabilities. The group, which is being launched ... other caregivers the opportunity to share stories and advice, seek help, and continue their ...
(Date:12/2/2016)... (PRWEB) , ... December 02, 2016 , ... ... inspirational interview of two ostomy patients, standing as living proof that attitude and ... from digestive diseases and issues that spike around the holidays. This campaign will ...
(Date:12/2/2016)... Delaware (PRWEB) , ... December 02, 2016 , ... ... released a new version of its SaaS LIMS, CloudLIMS Lite. CloudLIMS Lite helps ... sample entry through labeling, storing, shipping and disposal. The new version is a ...
(Date:12/2/2016)... ... December 02, 2016 , ... Rijuven Corp launches rejiva ( http://www.rejiva.com ... and night. No other wearable health technology on the market can deliver all that ... poeple more meaningful insights about their health than the usual heart rate and steps ...
Breaking Medicine News(10 mins):
(Date:12/2/2016)... Dec. 2, 2016  The Addiction Treatment Advisory ... of Managed Care Pharmacy (AMCP), has released detailed ... address the opioid addiction crisis, including through improved ... ATAG,s newly released paper, "The Role ... Naloxone," addresses many issues around gaps and barriers ...
(Date:12/2/2016)...  Maxor National Pharmacy Services, LLC ("Maxor"), today announced that ... The combination of Texas -based Maxor Specialty ... bring together both company,s clinical expertise and high-touch patient service ... specialty pharmacy. About Maxor ... , , ...
(Date:12/2/2016)... -- CVS Health Corporation (NYSE: CVS ) ... December 15, 2016, beginning at 8:00 a.m. (ET). Senior members ... in-depth review of the company,s strategies to drive long-term ... discuss 2017 earnings guidance during the event. ... be broadcast simultaneously on the Investor Relations portion of ...
Breaking Medicine Technology: